InsiderTrades.com logo

PALI Insider Trading

Insider Ownership Percentage: 0.05%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $10,298.75

Palisade Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Palisade Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Palisade Bio Share Price & Price History

Current Price: $1.79
Price Change: ▲ Price Increase of +0.18 (11.18%)
As of 02/24/2026 05:00 PM ET

This chart shows the closing price history over time for PALI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Palisade Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/12/2026John David FinleyCEOSell3,896$1.75$6,818.0027,353View SEC Filing Icon  
2/12/2026Mitchell Lawrence JonesInsiderSell1,989$1.75$3,480.7513,263View SEC Filing Icon  
5/28/2024Donald Allen WilliamsDirectorBuy1,000$4.86$4,860.001,000View SEC Filing Icon  
5/24/2024John David FinleyCEOBuy1,000$4.81$4,810.008,437View SEC Filing Icon  
1/31/2024Donald Allen WilliamsDirectorBuy666$9.00$5,994.002,000View SEC Filing Icon  
9/27/2023Donald Allen WilliamsDirectorBuy1,333$8.10$10,797.301,333View SEC Filing Icon  
9/27/2023John David FinleyCEOBuy1,000$8.10$8,100.002,892View SEC Filing Icon  
9/14/2023Robert J. TrenschelDirectorSell20$9.60$192.00View SEC Filing Icon  
9/13/2023John David FinleyCEOBuy1,000$9.90$9,900.001,892View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Palisade Bio (NASDAQ:PALI)

11.79% of Palisade Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PALI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Palisade Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/23/2026Virtu Financial LLC11,870$28K0.0%N/A0.008%Search for SEC Filing on Google Icon
2/18/2026Creek Drive Management Group LLC307,500$0.72M0.5%N/A0.206%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd21,669$51K0.0%+53.8%0.015%Search for SEC Filing on Google Icon
2/18/2026Ikarian Capital LLC274,978$0.65M0.0%N/A0.185%Search for SEC Filing on Google Icon
2/18/2026Squadron Capital Management LLC4,500,000$10.58M4.5%N/A3.020%Search for SEC Filing on Google Icon
2/18/2026Sphera Funds Management LTD.184,100$0.43M0.1%N/A0.124%Search for SEC Filing on Google Icon
2/18/2026Superstring Capital Management LP367,103$0.86M0.5%N/A0.246%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd240,586$0.57M0.0%N/A0.161%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC1,871,420$4.40M0.1%N/A1.256%Search for SEC Filing on Google Icon
2/18/2026Perceptive Advisors LLC12,050,000$28.32M0.5%N/A8.087%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC294,486$0.69M0.0%N/A0.198%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC10,540,334$24.82M0.0%N/A7.074%Search for SEC Filing on Google Icon
2/18/2026Eversept Partners LP5,391,548$12.67M0.6%N/A3.618%Search for SEC Filing on Google Icon
2/18/2026Commodore Capital LP11,445,000$26.90M1.8%N/A7.681%Search for SEC Filing on Google Icon
2/18/2026Artia Global Partners LP1,992,367$4.68M0.6%N/A1.337%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.325,367$0.77M0.0%N/A0.218%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC132,648$0.31M0.0%N/A0.089%Search for SEC Filing on Google Icon
2/18/2026ACT Capital Management LLC150,000$0.35M0.3%N/A0.101%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC2,004,845$4.71M0.3%N/A1.346%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC11,231$26K0.0%N/A0.008%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers10,512$25K0.0%N/A0.007%Search for SEC Filing on Google Icon
2/17/2026RA Capital Management L.P.7,124,116$16.74M0.2%N/A4.781%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD1,577,856$3.71M0.0%N/A1.059%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.4,500,000$10.58M0.0%N/A3.020%Search for SEC Filing on Google Icon
2/17/2026Diadema Partners LP166,049$0.39M0.1%N/A0.111%Search for SEC Filing on Google Icon
2/17/2026B Group Inc.4,500,000$10.58M7.8%N/A3.020%Search for SEC Filing on Google Icon
2/17/2026Atom Investors LP14,041$33K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/17/2026Persistent Asset Partners Ltd416,035$0.98M0.4%N/A0.279%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC322,090$0.76M0.0%N/A0.216%Search for SEC Filing on Google Icon
2/16/2026OMERS ADMINISTRATION Corp108,000$0.25M0.0%N/A0.072%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC14,780$35K0.0%N/A0.010%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 106,636$0.25M0.0%N/A0.072%Search for SEC Filing on Google Icon
2/13/2026Hudson Bay Capital Management LP656,460$1.54M0.0%N/A0.441%Search for SEC Filing on Google Icon
2/13/2026Virtus Advisers LLC46,000$0.11M0.1%N/A0.031%Search for SEC Filing on Google Icon
2/13/2026Vivo Capital LLC2,293,578$5.39M0.3%N/A1.539%Search for SEC Filing on Google Icon
2/13/2026Exome Asset Management LLC758,203$1.78M0.9%N/A0.509%Search for SEC Filing on Google Icon
2/13/2026State Street Corp643,997$1.51M0.0%N/A0.432%Search for SEC Filing on Google Icon
2/13/2026Vontobel Holding Ltd.20,000$47K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/13/2026Caitong International Asset Management Co. Ltd29,388$69K0.2%N/A0.020%Search for SEC Filing on Google Icon
2/13/2026Platinum Investment Management Ltd.664,087$1.56M0.4%N/A0.446%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC343,686$0.81M0.0%N/A0.231%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC16,650$39K0.0%N/A0.011%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC2,382,500$5.60M0.0%N/A1.599%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC15,154$36K0.0%N/A0.010%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.5,092,562$11.97M0.0%N/A3.418%Search for SEC Filing on Google Icon
2/11/2026BIT Capital GmbH305,000$0.72M0.0%N/A0.205%Search for SEC Filing on Google Icon
2/11/2026WINTON GROUP Ltd14,891$35K0.0%N/A0.010%Search for SEC Filing on Google Icon
2/10/2026TD Asset Management Inc204,448$0.48M0.0%N/A0.137%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.557,565$1.31M0.0%N/A0.374%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC1,565,452$3.68M0.0%+5,780.7%1.051%Search for SEC Filing on Google Icon
2/9/2026Jefferies Financial Group Inc.46,761$0.11M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/2/2026Total Clarity Wealth Management Inc.29,935$70K0.0%N/A0.020%Search for SEC Filing on Google Icon
5/15/2025Armistice Capital LLC144,764$99K0.0%+37.4%3.292%Search for SEC Filing on Google Icon
2/17/2025Cetera Investment Advisers70,006$0.12M0.0%N/A2.531%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.8,200$29K0.0%N/A0.542%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC27,858$0.13M0.0%-96.1%2.976%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP5,643,007$0.56M0.2%N/A25.791%Search for SEC Filing on Google Icon
10/27/2022Sargent Investment Group LLC670,000$76K0.0%+179.2%3.062%Search for SEC Filing on Google Icon
7/26/2022Sargent Investment Group LLC240,000$98K0.0%+84.6%1.097%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP333,954$0.43M0.1%N/A2.460%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.28,841$76K0.0%+16.7%0.223%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Palisade Bio logo
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor, currently under pre-clinical development as a therapeutic for patients living with inflammatory bowel diseases, including ulcerative colitis and Crohn's disease (CD), as well as develops PALI-1908, an oral, selective PDE4 inhibitor prodrug that is locally bioactivated in the terminal ileum of CD patients, currently in the research stage. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California; a co-development and distribution agreement with Newsoara Biopharma Co., Ltd; and a transformative strategic collaboration with Strand Life Sciences for advancing precision medicine for ulcerative colitis therapy. The company is based in Carlsbad, California.
Read More on Palisade Bio

Today's Range

Now: $1.79
Low: $1.61
High: $1.80

50 Day Range

MA: $1.86
Low: $1.49
High: $2.50

52 Week Range

Now: $1.79
Low: $0.53
High: $2.64

Volume

5,586,040 shs

Average Volume

4,820,798 shs

Market Capitalization

$266.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Who are the company insiders with the largest holdings of Palisade Bio?

Palisade Bio's top insider investors include:
  1. John David Finley (CEO)
  2. Mitchell Lawrence Jones (Insider)
  3. Donald Allen Williams (Director)
Learn More about top insider investors at Palisade Bio.

Who are the major institutional investors of Palisade Bio?

Palisade Bio's top institutional shareholders include:
  1. Perceptive Advisors LLC — 8.09%
  2. Commodore Capital LP — 7.68%
  3. Janus Henderson Group PLC — 7.07%
  4. RA Capital Management L.P. — 4.78%
  5. Eversept Partners LP — 3.62%
  6. Franklin Resources Inc. — 3.42%
Learn More about top institutional investors of Palisade Bio stock.

Which major investors are buying Palisade Bio stock?

During the previous quarter, PALI stock was bought by institutional investors including:
  1. Perceptive Advisors LLC
  2. Commodore Capital LP
  3. Janus Henderson Group PLC
  4. RA Capital Management L.P.
  5. Eversept Partners LP
  6. Franklin Resources Inc.
  7. B Group Inc.
  8. Adage Capital Partners GP L.L.C.
Within the previous year, these company insiders have bought Palisade Bio stock:
  1. John David Finley (CEO)
  2. Mitchell Lawrence Jones (Insider)
Learn More investors buying Palisade Bio stock.